Armata Pharmaceuticals Inc (NYSE: ARMP) — Healthcare · Share Price, Chart & Market Data
About: Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.
Sector: Healthcare
Industry: Biotechnology
Latest price: $12.92 (-4.51%)
ARMPArmata Pharmaceuticals Inc
Loading watchlist status…
Trade ARMP now
Armata Pharmaceuticals Inc share price
ARMP price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 1:16 pm GMT+0
ARMP price performance
-12.703%
5D
54.361%
1M
96.951%
YTD
816.312%
1Y
ARMP price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 1:16 pm GMT+0
ARMP details
ARMP Market Signals